Scholars Central

Review articlePublished 30 Dec 2022

Precision Medicine and Translation of Human-Induced Pluripotent Stem Cells: Review

Authors: Kenza Tani

Translational Biomedicine

Volume 13 · Issue 12 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The future of biomedical research has undergone a significant change as a result of the possibility of altering the flexibility of terminally differentiated cells toward pluripotency. Human-induced pluripotent stem cells (iPSCs) offer a fresh source of therapeutic cells free of the moral quandaries or immunological restrictions associated with human embryonic stem cells. iPSCs also provide significant benefits over traditional approaches of studying human diseases. Three key uses of iPSC technology have emerged since its inception: disease modelling, regenerative medicine, and drug development. Here, we thoroughly cover the most recent developments in iPSC technology in connection to fundamental, clinical, and public health. Keywords Pluripotent; Stem Cells; Translation

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Translational Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTranslational Biomedicine
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Kenza Tani”